0
2

To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

6/9/2026, 8:05 AM

Summary of Bill HR 9190

H.R. 9190 in the 119th Congress, introduced on June 8, 2026, aims to amend the Federal Food, Drug, and Cosmetic Act to allow patients diagnosed with life-threatening diseases or severely debilitating illnesses to access investigational individualized medical treatments.

Current Status of Bill HR 9190

Bill HR 9190 is currently in the status of Bill Introduced since June 8, 2026. Bill HR 9190 was introduced during Congress 119 and was introduced to the House on June 8, 2026.  Bill HR 9190's most recent activity was Referred to the House Committee on Energy and Commerce. as of June 8, 2026

Bipartisan Support of Bill HR 9190

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 9190

Primary Policy Focus

Alternate Title(s) of Bill HR 9190

To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.
To amend the Federal Food, Drug, and Cosmetic Act to authorize the use of investigational individualized medical treatments by patients diagnosed with a life-threatening disease or condition or severely debilitating illness, and for other purposes.

Comments